Board of Directors

Each member of our distinguished Board of Directors has extensive, exemplary experience in growing companies in the field of biologics. They are committed to providing an independent and objective source of counsel and to helping guide GBI in its mission as we continue to develop and manufacture highly complex, targeted biopharmaceuticals in a cost-effective and timely manner.

Karl Pinto, MBA Chairman of the Board
Darrin T. Schellin Chief Executive Officer
Divya Menezes, MD Board Member
Kent Payne, Board Member at GBI
Kent Payne, Ph.D. Board Member
Brandon J. Price, Ph.D. Board Member
Nikhil Puri Board Member
Steven Vorgity Vice President of Finance & Company Secretary